(Q44505402)

English

Clinicopathological significance of HER2/neu genetic heterogeneity in HER2/neu non-amplified invasive breast carcinomas and its concurrent axillary metastasis

scientific article published on 28 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Clinicopathological significance of HER2/neu genetic heterogeneity in HER2/neu non-amplified invasive breast carcinomas and its concurrent axillary metastasis (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

author name string

Hedyeh Shafi

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Kristine Astvatsaturyan

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Fai Chung

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

James Mirocha

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Michael Schmidt

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Shikha Bose

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

28 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Journal of Clinical Pathology

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

66

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

649-654

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201403

21 January 2018

Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201403

21 January 2018

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201403

21 January 2018

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201403

21 January 2018

Genotypic intratumoral heterogeneity in breast carcinoma with HER2/neu amplification: evaluation according to ASCO/CAP criteria.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201403

21 January 2018

'Genetic heterogeneity' in HER2/neu testing by fluorescence in situ hybridization: a study of 2,522 cases

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201403

21 January 2018

Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201403

21 January 2018

Heterogeneous HER2 gene amplification: impact on patient outcome and a clinically relevant definition

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201403

21 January 2018

The clonal evolution of tumor cell populations

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201403

21 January 2018

Cancer: the evolved consequence of a destabilized genome

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201403

21 January 2018

Biological characteristics of breast cancer at the primary tumour and the involved lymph nodes

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201403

21 January 2018

Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201403

21 January 2018

Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201403

21 January 2018

Molecular alterations between the primary breast cancer and the subsequent locoregional/metastatic tumor

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201403

21 January 2018

Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201403

21 January 2018

Identifiers

10.1136/JCLINPATH-2012-201403

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44505402&oldid=2145955613"